Table 4 Baseline characteristics and change in AAD, DAD and PWV after 1 year treatment with RAAS inhibition in 25 subjects

Age

64.2 ± 11.8

Male gender, N (%)

22 (88%)

Body mass index, kg/m²

29.1 ± 3.4

Duration of diabetes, years

5.2 ± 4.5

HbA1c, %

7.6 ± 1.5

HbA1c, mmol/mol

60.1 ± 17.7

Median HbA1c since diagnosis, mmol/mol

63.4 ± 17.6

Maximum HbA1c since diagnosis, mmol/mol

86.6 ± 25.6

24 h systolic BP, mmHg

136.7 ± 19.3

24 h diastolic BP, mmHg

72.9 ± 10.1

Total cholesterol, mmol/L

4.1 ± 1.0

Smoking, N (%)

4 (16%)

Serum aldosterone, pmol/L

337.0 ± 190.8

AAD (10⁻³ mmHg⁻¹)

1.51 ± 1.15

DAD (10⁻³ mmHg⁻¹)

1.98 ± 1.29

PWV (m/s)

8.95 ± 2.60